Farm Animal Drugs Market Key Players and Opportunities by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Farm Animal Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Anti-Infective, Parasiticides, Anti-Inflammatory, Anesthetics, Analgesics, Hormones and Related Product, and Others), Animal Type (Livestock Animal and Equine), Route of Administration (Oral, Parenteral, Topical, and Others), and Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores, and Others), and Geography

  • Report Date : Nov 2021
  • Report Code : TIPRE00005797
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 240

The farm animal drugs market is projected to grow from US$ 18,253.09 million in 2021 to US$ 28,364.08 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028.

Drugs play a key role in maintaining the health of farm animals and improving the economic condition of farm producers. The need for better productivity has become important more, as the population are looking for nutritious and disease-free food products. The pharmacologically active compounds help prevent the passing of diseases from animals to humans. Farm animal’s health have been considerably shaped by the use of drugs. Farm animal drugs are medicines used for healthcare-based practices for diagnosis, cure, mitigation, treatment, or prevention of diseases that could affect livestock. These medicines are used as per strict requirements based on their essentiality to maintain the well-being of farm animals. Simply said, farm animal drugs are a key factor supporting the growth of the livestock industry across the world. Factors such as the growing use of pain management drugs in farm animals, rising incidence of foodborne diseases and infections, and surging demand for quality pharmaceuticals and food security boost the growth of the farm animal drugs market. However, the side effects of drugs in animals and strict government rules related to the usage of farm animal drugs hamper the growth of the market.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Farm Animal Drugs Market: Strategic Insights

farm-animal-drugs-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.



Market Insights

Growing Use of Pain Management Drugs in Farm Animals Bolsters Farm Animal Drugs Market Growth

Pain in farm animals is often associated with common production diseases, such as lameness and mastitis, and is brought to the animal through routine husbandry practices, such as castration and tail docking. Pain causes behavioral, autonomic, and neuroendocrine changes; and induces a negative affective state, compromises animal welfare, and harms the profitability of agriculture.

Controlling pain is essential to the health of all animals. In 2018, the Food and Drug Administration (FDA) approved the first pain reliever for use in a food-producing animal. Foot rot is a common cause of pain and lameness in cattle of all ages and breeds. The disease is seen in cattle kept in barns and pylons, as well as cattle on pasture. Banamine Transdermal is approved to treat the pain associated with foot rot in cattle, and it can only be obtained with a prescription. The FDA Center for Veterinary Medicine promotes and protects animal health by ensuring safe and effective medicines are available to animals. Working with pharmaceutical companies to develop and approve drugs to control pain in all animals, including food-producing animals, is an integral part of this mission.

There are several routine practices in animal husbandry that demand efficient pain management in animals. Some routine procedures that cause pain in farm animals include castration, dehorning or disbudding. and branding. The most common drugs used for pain control in farm animals include nonsteroidal anti-inflammatory drugs (NSAIDs), local anesthetics, α2-agonists and opioids. Efficient management of pain in food-producing animals has gradually become a matter of consumer concern worldwide, and this has therefore resulted in high interest of regulatory authorities. Consequently, the animal husbandry industry worldwide is evolving with new practices and use of off-label analgesics with keeping animal welfare and profitability in consideration. This has therefore led to significant rise in analgesic drugs such as lidocaine, xylazine, detomidine, medetomidine, ketamine, tolfenamic acid, buprenephrine, etc. in general pain management practice for farm animals. 

Consumers are becoming increasingly aware and concerned about the welfare of animals raised for food. This has put pressure on suppliers to ensure that animals entering their systems are treated humanely. Measures are being taken for addressing such demand. Only one drug is approved in the US to control interdigital phlegmon (foot rot) pain in non-lactating cattle. Therefore, using medications for pain management in elective procedures, such as dehorning and castration, in cattle or analgesia in lactating dairy cows and pigs is considered an extra-label drug use. It is regulated as per the clarification on the use of veterinary drugs law. Flunixin, meloxicam, and ketoprofen are nonsteroidal anti-inflammatory drugs with supportive research on on-farm analgesia. Several products, such as local and regional anesthetics, opioids, and nonsteroidal anti-inflammatory drugs (NSAIDs), are available in the market to relieve pain in animals.

Product Type-Based Insights

Based on product type, the farm animal drugs market is segmented into anti-infective, parasiticides, anti-inflammatory, anesthetics, analgesics, hormones and related product, and others. The parasiticides segment held the largest market share in 2021 and is expected to register the highest CAGR during the forecast period.

Animal Type-Based Insights

Based on animal type, the farm animal drugs market is bifurcated into livestock animals and equine. The livestock animals segment held the largest market share of 90.77% in 2021, and is expected to retain its dominance during the forecast period.

Route of Administration-Based Insights

Based on route of administration, the farm animal drugs market is segmented into oral, parenteral, topical, and others. The oral segment held the largest market share of 90.77% in 2021, and is expected to retain its dominance during the forecast period.

Distribution Channel-Based Insights

Based on distribution channel, the farm animal drugs market is segmented into veterinary hospitals, veterinary clinics, pharmacies and drug stores, and others. The veterinary hospitals segment held the largest market share in 2021, whereas the market for the veterinary clinics segment is expected to grow at a CAGR of 6.9% during the forecast period.

Various companies operating in the farm animal drugs market are adopting strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain brand name, and meet the growing demand from end users. 

Farm Animal Drugs Market Regional Insights

The regional trends and factors influencing the Farm Animal Drugs Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Farm Animal Drugs Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

farm-animal-drugs-market-global-geography
  • Get the Regional Specific Data for Farm Animal Drugs Market

Farm Animal Drugs Market Report Scope

Report Attribute Details
Market size in 2021 US$ 18.25 Billion
Market Size by 2028 US$ 28.36 Billion
Global CAGR (2021 - 2028) 6.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product Type
  • Anti-Infective
  • Parasiticides
  • Anti-Inflammatory
  • Anesthetics
  • Analgesics
  • Hormones and Related Product
By Animal Type
  • Livestock Animal and Equine
By Route of Administration
  • Oral
  • Parenteral
  • Topical
By Distribution Channel
  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies and Drug Stores
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • PHIBRO ANIMAL HEALTH CORPORATION
  • Zoetis Inc.
  • Ceva
  • Elanco
  • Virbac
  • INTAS PHARMACEUTICALS LTD.
  • Alembic Pharmaceuticals Limited
  • Boehringer Ingelheim International GmbH
  • MSD Animal Health

  • Farm Animal Drugs Market Players Density: Understanding Its Impact on Business Dynamics

    The Farm Animal Drugs Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Farm Animal Drugs Market are:

    1. PHIBRO ANIMAL HEALTH CORPORATION
    2. Zoetis Inc.
    3. Ceva
    4. Elanco
    5. Virbac

    Disclaimer: The companies listed above are not ranked in any particular order.


    farm-animal-drugs-market-cagr

    • Get the Farm Animal Drugs Market top key players overview

    Farm Animal Drugs Market – by Product Type

    • Anti-Infective
    • Parasiticides
    • Anti-Inflammatory
    • Anesthetics
    • Analgesics
    • Hormones and Related Product
    • Others

    Farm Animal Drugs Market – by Animal Type

    • Livestock Animal
    • Equine

    Farm Animal Drugs Market – by Route of Administration

    • Oral
    • Parenteral
    • Topical
    • Others

    Farm Animal Drugs Market – by Distribution Channel

    • Veterinary Hospitals
    • Veterinary Clinics
    • Pharmacies and Drug Stores
    • Others 

    Farm Animal Drugs Market – by Geography

    •   North America

    • US
    • Canada
    • Mexico

    •   Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe

    •   Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific

    •   Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa

    •   South & Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of South and Central America

    Company Profiles

    • PHIBRO ANIMAL HEALTH CORPORATION
    • Zoetis Inc.
    • Ceva
    • Elanco
    • Virbac
    • INTAS PHARMACEUTICALS LTD.
    • Alembic Pharmaceuticals Limited
    • Boehringer Ingelheim International GmbH
    • MSD Animal Health
    • Vetoquinol SA

    Frequently Asked Questions

    Which route of administration held the largest share in the farm animal drugs market?

    The oral segment dominated the global farm animal drugs market and accounted for the largest revenue share of 42.81% in 2021.

    Which distribution channel held the largest share in the farm animal drugs market?

    The veterinary hospitals segment dominated the global farm animal drugs market and accounted for the largest revenue share of 36.70% in 2021.

    Who are the key players in the farm animal drugs market?

    The farm animal drugs market majorly consists of the players such PHIBRO ANIMAL HEALTH CORPORATION, Zoetis Inc., Ceva, Elanco, Virbac, INTAS PHARMACEUTICALS LTD., Alembic Pharmaceuticals Limited, Boehringer Ingelheim International GmbH, MSD Animal Health, and Vetoquinol SA among others.

    Which product type led the farm animal drugs market?

    The parasiticides segment dominated the global farm animal drugs market and held the largest revenue share of 26.88% in 2021.

    Which animal type held the largest share in the farm animal drugs market?

    The livestock animals segment dominated the global farm animal drugs market and accounted for the largest revenue share of 90.77% in 2021

    What are the driving factors for the farm animal drugs market across the globe?

    Key factors that are driving the growth of this market are the growing use of pain management drugs in farm animals, rising incidence of foodborne diseases and infections, and surging demand for quality pharmaceuticals and food security are expected to boost the market growth for the farm animal drugs over the years.

    What is farm animal drug?

    Drugs play a key role in maintaining the health of farm animals and improving the economic condition of farm producers. The need for better productivity has become important more, as the population are looking for nutritious and disease-free food products. The pharmacologically active compounds help prevent the passing of diseases from animals to humans. Farm animal’s health have been considerably shaped by the use of drugs. Farm animal drugs are medicines used for healthcare-based practices for diagnosis, cure, mitigation, treatment, or prevention of diseases that could affect livestock. These medicines are used as per strict requirements based on their essentiality to maintain the well-being of farm animals. Simply said, farm animal drugs are a key factor supporting the growth of the livestock industry across the world.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies - Farm Animal Drugs Market

    1. PHIBRO ANIMAL HEALTH CORPORATION
    2. Zoetis Inc.
    3. Ceva
    4. Elanco
    5. Virbac
    6. INTAS PHARMACEUTICALS LTD.
    7. Alembic Pharmaceuticals Limited
    8. Boehringer Ingelheim International GmbH
    9. MSD Animal Health
    10. Vetoquinol SA
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo